Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment. (Q45905920)

17 December 2017

title

Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment. (English)

1 reference

17 December 2017

author

Kaisa Lehti

2

1 reference

17 December 2017

author name string

Sirpa Loukovaara

1

1 reference

17 December 2017

Alexandra Robciuc

3

1 reference

17 December 2017

Timo Pessi

4

1 reference

17 December 2017

Juha M Holopainen

5

1 reference

17 December 2017

Katri Koli

6

1 reference

17 December 2017

Ilkka Immonen

7

1 reference

17 December 2017

Jorma Keski-Oja

8

1 reference

17 December 2017

publication date

12 November 2013

1 reference

17 December 2017

Graefe's Archive for Clinical and Experimental Ophthalmology

published in

1 reference

17 December 2017

volume

252

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

881-888

1 reference

17 December 2017

Pathogenesis of rhegmatogenous retinal detachment: predisposing anatomy and cell biology

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Glial epiretinal membranes and contraction. Immunohistochemical and morphological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Ocular angiogenesis: the role of growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Vitreous levels of VEGF, IL-8, and TNF-alpha in retinal detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Angiopoietins: a link between angiogenesis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Gelatinase B in proliferative vitreoretinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Matrix metalloproteinases in human diabetic and nondiabetic vitreous

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Production and Activation of Matrix Metalloproteinase-2 in Proliferative Diabetic Retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Correlation of the extent and duration of rhegmatogenous retinal detachment with the expression of matrix metalloproteinases in the vitreous.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Erythropoietin as a retinal angiogenic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

From oxygen to erythropoietin: relevance of hypoxia for retinal development, health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Elevated erythropoietin in vitreous with ischemic retinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

The yin, the yang, and the Angiopoietin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood-retinal barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Angiopoietin-1 protects the adult vasculature against plasma leakage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Angiopoietin-1 is an apoptosis survival factor for endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Signaling and functions of angiopoietin-1 in vascular protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

TGF-β1 signaling controls retinal pericyte contractile protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Profibrotic cytokines in aqueous humour correlate with aqueous flare in patients with rhegmatogenous retinal detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Proteome Profiling of Vitreoretinal Diseases by Cluster Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

21 January 2018

12 December 2020

ANTIANGIOGENIC ISOFORMS OF VASCULAR ENDOTHELIAL GROWTH FACTOR PREDOMINATE IN SUBRETINAL FLUID OF PATIENTS WITH RHEGMATOGENOUS RETINAL DETACHMENT AND PROLIFERATIVE VITREORETINOPATHY

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Correlation of matrix metalloproteinase levels with the grade of proliferative vitreoretinopathy in the subretinal fluid and vitreous during rhegmatogenous retinal detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2508-Z

Apoptotic photoreceptor degeneration in experimental retinal detachment

21 January 2018

1 reference

12 December 2020

Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye

1 reference

12 December 2020

Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes

1 reference

12 December 2020

Apoptosis and other cell death mechanisms after retinal detachment: implications for photoreceptor rescue

1 reference

12 December 2020

Rapid changes in the expression of glial cell proteins caused by experimental retinal detachment.

1 reference

12 December 2020

ProMMP-9 (92 kDa gelatinase) in vitreous fluid of patients with proliferative diabetic retinopathy

1 reference

12 December 2020

Characterization of an endogenous metalloproteinase in human vitreous

1 reference

12 December 2020

A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy.

1 reference

12 December 2020

Deficient activation and different expression of transforming growth factor-beta isoforms in active proliferative diabetic retinopathy and neovascular eye disease

1 reference

12 December 2020

Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy

1 reference

12 December 2020

Matrix metalloproteinases and their inhibitors in human vitreous.

1 reference

12 December 2020

An updated classification of retinal detachment with proliferative vitreoretinopathy

1 reference

12 December 2020

10.1007/S00417-013-2508-Z

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

1016310025

0 references

1 reference

17 December 2017